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The DDB1-CUL4-RBX1 (CRL4) ubiquitin ligase family
regulates a diverse set of cellular pathways through
dedicated substrate receptors (DCAFs). The DCAF
DDB2 detects UV-induced pyrimidine dimers in the
genome and facilitates nucleotide excision repair.
We provide the molecular basis for DDB2 receptor-
mediated cyclobutane pyrimidine dimer recognition
in chromatin. The structures of the fully assembled
DDB1-DDB2-CUL4A/B-RBX1 (CRL4DDB2) ligases re-
veal that the mobility of the ligase arm creates a
defined ubiquitination zone around the damage,
which precludes direct ligase activation by DNA
lesions. Instead, the COP9 signalosome (CSN) medi-
ates the CRL4DDB2 inhibition in a CSN5 independent,
nonenzymatic, fashion. In turn, CSN inhibition is
relieved upon DNA damage binding to the DDB2
module within CSN-CRL4DDB2. The Cockayne syn-
drome A DCAF complex crystal structure shows
that CRL4DCAF(WD40) ligases share common architec-
tural features. Our data support a general mecha-
nism of ligase activation, which is induced by CSN
displacement from CRL4DCAF on substrate binding
to the DCAF.INTRODUCTION
The evolutionarily conserved CUL4 E3 ligase family, in concert
with its DDB1 adaptor, regulates a diverse set of cellular1024 Cell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc.processes including development, transcription, replication
and DNA repair (Jackson and Xiong, 2009). Specificity is con-
ferred by a set of more than 50 WD40 containing substrate
receptors, also referred to as DCAFs (DDB1 CUL4 Associated
Factors) (Angers et al., 2006; Bennett et al., 2010; He et al.,
2006; Higa et al., 2006; Jin et al., 2006). A large fraction of these
targeting modules is directed toward chromatin-associated
proteins. One of the best characterized substrate receptors is
the damaged DNA binding protein 2 (DDB2), which binds to
UV-induced DNA pyrimidine dimers. The DDB2 receptor is part
of the DDB1-DDB2-CUL4-RBX1 E3 ligase complex (CRL4DDB2)
(Scrima et al., 2011). This bi-functional damage detection and
ubiquitin ligase complex serves in the repair of UV induced
DNA lesions in chromatin.
Exposure of the genomic DNA to ultraviolet light (UV) results
in the formation of covalent crosslinks between neighboring
pyrimidine nucleotides. These pyrimidine dimers, if left unre-
paired, stall transcription by RNA polymerase II (RNAPII). Unre-
paired lesions require error-prone translesion polymerases in
S phase (Friedberg, 2001), which potentially introduce onco-
genic mutations. Cyclobutane pyrimidine dimers (CPD) and
(6-4) pyrimidine-pyrimidone photoproducts (6-4PP) are the two
major photo-lesions, accounting for approximately 75% and
25% of genomic UV lesions, respectively (Mitchell et al., 1989).
Compared to 6-4PP, CPDs cause relatively minor thermody-
namic duplex destabilization (Jing et al., 1998), and are found
frequently obscured by organization into nucleosomes (Gale
and Smerdon, 1988). These biophysical and cellular properties
render CPDs the most difficult photo-lesion to detect. CPDs
are thereby highly mutagenic and major facilitators of skin
carcinogenesis (Hoeijmakers, 2009).
The mammalian global genome repair branch of nucleotide
excision repair (NER) surveys the genome for lesions and actively
repairs pyrimidine dimers (Aboussekhra et al., 1995). NER
thereby functions as a central pathway in safeguarding meta-
zoan cells against sun-induced skin carcinogenesis. XPC-
RAD23-Centrin2 acts as a lesion surveillance complex, recruiting
the core NER machinery to damaged sites (Volker et al., 2001).
Assembly of the NER complex results in rapid damage excision
and repair synthesis, with repair generally proceeding in a fast
and error-free fashion. While XPC is required for global genome
NER, it has little or no affinity for CPD lesions, and does not
recognize 6-4PP in the context of chromatin (Batty et al., 2000;
Sugasawa et al., 2001; Yasuda et al., 2005). Recently, XPC
recruitment to chromatin was shown to be facilitated by the
DDB1-DDB2 (UV-DDB) complex (Nishi et al., 2009). In the
absence of DDB2, XPC remains localized to 6-4PP and to
a lesser extent to CPDs, albeit with substantially delayed kinetics
(Sugasawa, 2010). The precise mechanism of XPC recruitment
to sites of UV damage, in the absence of DDB2 is unclear.
DDB2 binds to CPD and 6-4PP pyrimidine dimers with the high-
est reported affinity and specificity of all metazoan damage
recognition factors (Payne and Chu, 1994; Wittschieben et al.,
2005).Mutations in DDB2 give rise to XP complementation group
E (Tang and Chu, 2002). In DDB2-deficient XPE cells, CPD repair
is largely abolished, while 6-4PP repair is affected to a lesser
extent (Hwang et al., 1998; Moser et al., 2005; Tang et al.,
2000). The structural basis of 6-4PP recognition by DDB1-
DDB2 is known (Scrima et al., 2008) but it is currently unclear
how DDB2 recognizes CPD lesions, which are chemically
distinct from the 6-4PP and frequently encapsulated in nucleo-
somes (Gale and Smerdon, 1988).
DDB1-DDB2 appears constitutively bound to CUL4 which
targets XPC and DDB2 for ubiquitination (Sugasawa et al.,
2005). In addition, histones H2A, H3 and H4 surrounding the
lesion are ubiquitinated in a UV-dependent fashion (Guerrero-
Santoro et al., 2008; Kapetanaki et al., 2006; Wang et al.,
2006). DDB2 autoubiquitination leads to the loss of DNA damage
binding and rapid DDB2 degradation (Sugasawa et al., 2005).
XPC ubiquitination, in contrast, retains the complex at the site
of UV damage without immediate proteasomal degradation.
The differential response of XPC and DDB2 upon ubiquitination
has been linked to a ubiquitin-dependent damage handover
from CRL4DDB2 to XPC (Sugasawa et al., 2005). CRL4DDB2 is
found in complex with the COP9 signalosome (CSN) (Hannss
and Dubiel, 2011). CSN is an 8-subunit isopeptidase complex,
which via the proteolytic activity of its CSN5 subunit removes
the ubiquitin-like NEDD8 from cullins. NEDD8 is considered as
an activator and its removal renders the ligase complex inactive
(Furukawa et al., 2000). Recruitment of CRL4DDB2 to sites of DNA
damage in chromatin appears to correlate with CSN release
(Groisman et al., 2003; Takedachi et al., 2010). The molecular
mechanism triggering CRL4DDB2 activation in response to
damage binding is currently unresolved.
While the DDB2 substrate receptor recruits CRL4DDB2 to DNA
damage, other CRL4 substrate receptors are recruited by
protein epitopes. Prominent examples include DCAF1, CDT2
and the Cockayne syndrome A (CSA) protein (Lee and Zhou,
2007). All CRL4 substrate receptors are linked to CUL4 through
the DDB1 adaptor. CSA is functionally unrelated to DDB2 and
serves in the transcription coupled branch of NER. CRL4CSA isCrecruited to sites of CSB and stalled RNA polymerase II, where
it facilitates DNA repair and the subsequent transcription restart
(Tornaletti, 2009). Reported CRL4CSA ubiquitination targets
include the Cockayne syndrome B protein (CSB), a SWI/SNF
ATPase (Troelstra et al., 1992). CRL4DDB2 and CRL4CSA, as
well as other cullin-RING type ligases are inhibited by CSN
(Bennett et al., 2010). It is currently unclear how CSN inhibition
is retained at the majority of cellular cullin ligase complexes,
while CSN specifically dissociates from those ligases that
undergo activation in response to a given stimulus (i.e.: CSN
mediated dissociation and activation of CRL4DDB2 and CRL4CSA
in response to UV).
Here, we provide the molecular basis for CRL4DDB2 recruit-
ment to CPD lesions in chromatin, and characterize how the
damage recognition process results in ubiquitin ligase activation,
a process mediated by CSN. We present the structure of the
DDB1-CSA complex, which in conjunction with biochemical
data presented argues in favor of conserved architectural and
regulatory principles among CRL4 ligases.
RESULTS
CPD Recognition by DDB2 Involves b-Hairpin Insertion
and Lesion Flipping
TheDDB2 damage detectionmodule has previously been postu-
lated to undergo conformational changes upon binding of
a pyrimidine dimer resulting in CRL4DDB2 activation in vivo (Take-
dachi et al., 2010). We therefore focused on the structure of the
DDB1-DDB2 complex bound to CPD-containing duplexes, its
physiological substrate. DDB1-DDB2 has the highest reported
affinity for CPD lesions among metazoan damage recognition
factors. Its absolute affinity, however, was not sufficient to
allow successful crystallization in the presence of CPD duplexes.
We then engineered DDB1-DDB2 crystal contacts disfavoring
crystallization of the DNA-free (apo) state, biasing crystallization
toward CPD cocomplexes. This was done by mutating DDB1
contacts that occur only in the apo-DDB1-DDB2 crystal lattice,
as DDB1 is not involved in DNA binding (Figure S1 available
online). This approach led to the structuresofDDB1-DDB2bound
to four different cis-syn CPD-containing DNA duplexes,
observed in different space groups and crystal packing arrange-
ments (Figure 1; Figure S1). Due to the overall structural similarity
among theseDNAcocomplex structures, the discussion focuses
on the 3.0 A˚ resolution structure of DDB1-DDB2 bound to a
13-mer duplex having a 50 overhang on both strands (CPD#1).
Consistent with the DDB1-DDB2 6-4PP complex (Scrima
et al., 2008), the CPD-containing duplex is exclusively held by
the DDB2 WD40 propeller. The DNA traverses the central cavity
of the WD40 propeller along the axis defined by DDB2 blades 7
and 4, pointing away from DDB1 (Figure 1). A DDB2 b-hairpin,
comprising Phe371, Gln372 and His373 is inserted into the
minor groove of the duplex at the site of the CPD. Insertion of
this damage-recognition finger (Scrima et al., 2008) proceeds
with duplex unwinding of 12.6 (Figure S1D), widening of the
minor groove to 18 A˚ (Table S2) and extrusion of the CPD
into an extra-helical, flipped out conformation. The observed
kink angle of the cis-syn CPD DNA in the highest resolution
CPD complex is 45.ell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc. 1025
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Figure 1. DDB1-DDB2 in Complex with CPD-Containing Duplexes
(A) Cartoon representation of DDB1-DDB2-CPD. DDB2, green; DDB1 (BPA), red; (BPB), magenta; (BPC), yellow; DDB1-CTD, gray and the DNA in black and gray
for the damaged and undamaged strand respectively, with CPD shown in red. The DDB2 residues involved in DNA binding are shown as close-up.
(B) Schematic representation of DNA-protein interactions.
(C) Close-up view of the CPD/6-4PP fit to the hydrophobic binding pocket. (D) Close-up of the bound CPD lesion, demonstrating that the DDB2 binding pocket
preferentially accommodates the CPD.
See also Figure S1 and Tables S2 and S3.The DDB2 Binding Interface Is Specifically Tailored
toward CPD Recognition
The 6-4PP structure previously revealed few contacts between
DDB2 and the extruded 6-4PP (Scrima et al., 2008). The 6-4PP1026 Cell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc.has the pyrimidine-pyrimidone rings angled at 90 and can
therefore not fully engage the DDB2 damage recognition pocket
(Figures 1C and 1D). The boat-shaped cis-syn CPD, in contrast,
provides a high degree of surface complementarity through
packing with its hydrophobic carbons (at C5 and C6 positions)
against the hydrophobic core of the DDB2 pocket (Figure 1).
This interaction is stabilized by DDB2 residues Trp239, Ile213,
Gly192, and the Ca of Arg214. The four hydrophilic carbonyl
groups of the CPD (at the C2/C4 positions), located on the
opposing face, aresolventexposedandcontactwatermolecules.
The carboxylic group of Asp237 contacts the D+2 pyrimidine
nitrogen at N3. The overall arrangement results in a larger contact
area of 327 A˚2 for the CPD moiety versus 265 A˚2 for the 6-4PP.
Comparison with existing structures of protein-free CPD
duplexes indicated that the DNA conformation seen in the
DDB2-CPD complex (Figure 1) closely resembles previously
observed protein-free cis-syn CPD duplexes (Figure S1).
DDB2, through its pyrimidine dimer binding pocket and overall
DNA shape complementarity, thereby specifically supports
CPD recognition.
The DDB1-DDB2 Complex Does Not Change Its
Conformation in Response to Damage Binding
The DDB2 6-4PP, THF (Scrima et al., 2008) and CPD structures
illustrate that the DNA is intrinsically flexible and can adapt to
DDB2 despite differences in the DNA sequence (see Figure S1).
The plasticity of the DNA is contrasted with the rigidity of DDB2.
In all DNA bound and DNA free structures available, DDB2
including its b-hairpin does not change its conformation. Thus,
DDB2 serves as a rigid damage recognition unit. As a conse-
quence DDB2 binding to its physiological CPD substrate does
not trigger conformational changes that could serve as the signal
in ligase activation (see below).
DDB2 Mediated Detection of CPD Lesions in Chromatin
The DDB2 DNA binding interface has previously been proposed
to allow readout of lesions embedded in nucleosomes (Scrima
et al., 2008). This is of notable biological importance, as the
majority of CPDs appear encapsulated in nucleosomes (Gale
and Smerdon, 1988). The DNA curvature observed when bound
to DDB2 matches the nucleosomal curvature (Scrima et al.,
2008) which was proposed to facilitate pyrimidine dimer readout
through the minor groove. In order to test whether the DDB2
interface is compatible with nucleosomal damage detection,
damage-containing nucleosomes were initially prepared by UV
irradiation of DNA prior to the assembly of core particles
(Extended Experimental Procedures). Electrophoretic mobility
shift assays (EMSA) (Extended Experimental Procedures)
demonstrated that DDB1-DDB2 is able to specifically recognize
irradiated, linker free, mononucleosomes (Figure 2A). We sub-
sequently prepared nucleosomes containing a chemically
synthesized 6-4PP or CPD lesion (Figures 2B and 2C). Driven
by nucleosome positioning sequence consisting of alternating
A/T- andG/C-rich regions, these lesionswere located at the sites
where the minor groove is oriented away from the surface of the
histone octamer (Yasuda et al., 2005). DDB1-DDB2 recognizes
a single 6-4PP embedded in the nucleosome (Figure 2B, lanes
10–12) and comparable binding can be observed in the presence
of the equal amount of 6-4PP-containing naked DNA (Figure 2B,
lanes 13–16). Binding was also detected for the CPD-containing
nucleosomes (Figure 2C). CPD nucleosome binding was weaker
than that of the 6-4PP (Figures 2D and 2E), in line with its intrin-Csically lower helix destabilization (Jing et al., 1998). Binding of
CPD-containing nucleosomes was comparable, however, with
DDB2 affinities observed for naked CPD-containing DNA. The
DDB2 DNA binding interface in addition to being optimized for
CPD recognition, also confers compatibility for detecting CPDs
and 6-4PPs in nucleosomes.
Measurements of cellular diffusion rates identified the
CRL4DDB2 complex as the functional macromolecular entity in
DDB2 mediated DNA damage recognition (Luijsterburg et al.,
2007). We therefore examined binding of the fully assembled
CRL4DDB2 complex to irradiated nucleosomes (Figure 2F). Anal-
ogous to our findings with DDB1-DDB2, we observed that the
CRL4DDB2 complex is able to specifically recognize lesions in
nucleosomes, suggesting that the presence of CUL4 is com-
patible with damage recognition in chromatin. In an effort to
understand the interplay between damage binding and ligase
activation, we subsequently focused on the structure of the
CRL4DDB2 complex bound to damaged DNA duplexes.
Structures of DDB1-DDB2-CUL4A/B-RBX1 Bound
to Damage-Containing Duplexes
We first determined the structure of DDB1-DDB2-CUL4A-RBX1
(CRL4ADDB2) bound to a 12 bp DNA duplex containing a tetrahy-
drofuran (THF) lesion, a well characterized DDB2 substrate
(Wittschieben et al., 2005). The structure of this 290 kDa nucleo-
protein complex was refined by rigid body refinement to 5.9 A˚
resolution with an Rwork of 26.9% (Rfree of 27%) as outlined in
Extended Experimental Procedures. Fragments from previously
available high resolution structures of CUL4A (Angers et al.,
2006), DDB1, DDB2, and DNA (Scrima et al., 2008) were posi-
tioned using iterative cycles of molecular replacement searches
(Extended Experimental Procedures). The location of these indi-
vidual rigid bodies was validated with anomalous dispersion
methods using a selenomethionine (SeMet) labeled CRL4ADDB2
complex. Phases derived from molecular replacement were
used for calculation of anomalous difference Fourier electron
density maps, which allowed identification of peaks for 50% of
the 55 expected Se at 3.0 s (90% at 2.0 s). All peaks were
located within 5 A˚ of their predicted position (Figure S2D). Calcu-
lation of composite omit maps with CNS (Brunger et al., 1998)
further corroborated the correct placement of the different
domains of the large complex (Figure S2C). Well defined
2 mFobs-DFcalc density was observed for CUL4A, DDB1 (BPB,
BPC&BPA), DDB2 (helix-loop-helix motif and WD40 propeller)
and the 24 nucleotides of the DNA duplex. While density was
present for the segment of RBX1 residues 19–39 that integrates
into the CUL4A C-terminal b sandwich (Angers et al., 2006), no
density was observed for the remainder.
Figure 3 shows the structure of CRL4ADDB2 complex bound to
a damage-containing duplex. CRL4ADDB2 assumes an overall
U-shaped assembly, with two extended arms of nearly equal
length. The thicker arm is contributed by DDB1-DDB2 (extreme
dimensions 75 A˚ x 45 A˚), while the thinner arm comprises
CUL4A (75 A˚ x 23 A˚). The connection between them is made
by the N terminus of CUL4A (aa 39–96) in conjunction with the
DDB1-BPB domain (Angers et al., 2006). The DDB1-DDB2 and
CUL4A extended arms are angled at about 50. The overall
complex assumes an approximately square arrangementell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc. 1027
A B
C
0         60     200    600    2000
-          -         -         -          -
0        60      200    600    2000
+         +         +        +         +
UV-DDB (nM)
UV irradiated
NCP
p9HISAT DNA
1         2          3         4         5         6         7         8         9         10
NCP-Protein
complex
 +       +      +      +       +      +      + +      +      +       +      +      +       +
0     50    200   500 1000 2000 5000UV-DDB (nM)
UV irradiated
NCP
p9HISAT DNA
CRL4DDB2 (nM) 0     50    200   500 1000 2000 5000
1      2      3     4      5      6      7      8      9    10    11     12   13    14
NCP-Protein
complex
43210.00
0
20
40
60
80
100
NCP
naked
UV-DDB (fmol)
%
 b
ou
nd
6-4-Photoproduct
CPD DNA
UV-DDB (fmol) 0      2     4      0     2     4 0      2     4      0     2     4
-      -      -       +     +     + -      -      -       -      -      -
-      -      -      -      -      - -      -      -      +     +     +
0     1      2      4  
+     +     +      +  
+     +     +      +  
UV-DDB-NCP
UV-DDB-DNA
NCP
DNA
CPD NCP
1     2      3    4      5      6      7      8    9     10    11   12    13    14    15     16
D
6-4PP NCP
UV-DDB (fmol) 0      2     4      0     2     4 0     2    4      0     2     4
-      -      -       +     +     + -      -     -      -     -      -
-      -      -      -      -      - -     -    -     +    +     +
0     1     2     4  
+     +     +     + 
+     +     +     +
UV-DDB-NCP
UV-DDB-DNA
NCP
DNA
6-4PP DNA
1     2      3    4      5      6      7      8    9     10    11   12   13    14    15    16
432100
0
2
4
6
8
naked
NCP
UV-DDB (fmol)
%
 b
ou
nd
CPDE F
Figure 2. DDB2 Is Able to Recognize 6-4PP and CPDs Embedded in Nucleosomes
(A) EMSA of the DDB1-DDB2 complex binding to UV-damaged nucleosome core particles (NCP), indicated amounts of DDB1-DDB2 were incubated with
UV-damaged or undamaged mononucleosomes.
(B) EMSA analysis of DDB1-DDB2 binding to nucleosomes containing a specific 6-4PP lesion, indicated amounts of DDB1-DDB2were incubated with 0.2 fmol of
naked DNA (lanes 1-6), mononucleosomes (lanes 7–12) or both (lanes 13–16). The nondamaged DNA control is shown as indicated.
(C) As in (B) using CPD containing nucleosomes.
(D) and (E) Quantitative analysis of DDB1-DDB2 binding to free lesion containing DNA or to a lesion embedded in the nucleosomes 6-4PP (B) or CPD (C). (F) EMSA
analysis of DDB1-DDB2 and CRL4ADDB2 complex binding to UV-damaged mononucleosomes.
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Figure 3. The Structure of the CRL4ADDB2 Complex Bound to THF-Containing Duplex
Cartoon representation of the CRL4ADDB2 complex structure: DDB2, green; DDB1 (BPA), red; (BPB), magenta; (BPC), orange, DDB1-CTD, gray; CUL4A, cullin
repeat domains (CRD1-3) and C-terminal domain (CTD) depicted in gray to black; RBX1 in cyan. The DNA is shown in black and orange for the undamaged and
damaged strand respectively. DDB1 and DDB2 are shown as surface in the bottom panel. See also Figure S2.
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(160 A˚ x 140 A˚). The largely helical CUL4A fold is attached exclu-
sively to the BPB WD40 propeller of DDB1 (Figure 3). The
observed distances between the CUL4A arm and the remainder
of the DDB1 (BPC+BPA) propellers are generally more than 15-
20 A˚. The distance between CUL4A and the DNA duplex is
around 50 A˚. This arrangement excludes specific interactions
between CUL4A and the DNA, or CUL4A and the BPA and
BPC propellers of DDB1 (Figure 3).
The CUL4A and CUL4B Ligases Are Structurally
Indistinguishable
Since human cells possess two CUL4 isoforms, CUL4A and
CUL4B (Jackson and Xiong, 2009) with DDB1-DDB2 reported
to exist in complex with both of them (Groisman et al., 2003;
Wang et al., 2006), we determined the crystal structure of
CUL4B-RBX1 bound toDDB1-DDB2 in the presence of a second
12 bp THF containing duplex DNA (7.4 A˚ resolution). While the
cullin fold of CUL4B (aa 192–913) has high sequence identity
to CUL4A (84% over 722 residues), the CUL4B N terminus is
unique to CUL4B. The CUL4B aa 1–191 N terminus was pre-
dicted to bemostly unstructured andwas removed prior to coex-
pression of the CRL4DDB2 complex.
In the absence of known CUL4B structures, we first deter-
mined the structure of CUL4B (in complex with CAND1) at
3.8 A˚ resolution (Extended Experimental Procedures). Analysis
of CUL4A and CUL4B folds revealed superimposable structures
(rmsd of 1.54 A˚ over 677 residues) rendering the two homologs
structurally indistinguishable (see Figure 4C and Figure S3 for
the mapping of CUL4B mutations resulting in X-linked mental
retardation).
The CUL4 E3 Ligase Freely Rotates Around a Rotation
Axis Defined by DDB1 and the Damage
The structure of the DDB1-DDB2-CUL4B-RBX1 (CRL4BDDB2)
complex was solved following a similar strategy, as outlined for
CRL4ADDB2 (Extended Experimental Procedures). The overall
architecture of the two CRL4BDDB2 complexes, observed in the
asymmetric unit was comparable with CRL4ADDB2 (Figure 4).
Clear density for RBX1, again was only visible for aa 19–39 in
both molecules of CRL4BDDB2. Comparison of the CRL4ADDB2
with the two CRL4BDDB2 molecules revealed the DDB1-BPB
domain in three different rotational states. As the BPB domain
is the anchor point of the CUL4 ligase, its mobility directly trans-
lates into the mobility of the entire ligase arm. Within the three
molecules observed in our study (Figures 4A and 4B), CUL4
rotates around 60 along an axis defined by the damage and
DDB1 (BPB propeller) (Figure 4). Minimal distances observed
between CUL4B and DNA, and between CUL4B and DDB1
(BPC), for the two CUL4B molecules were between 25–35 A˚
and 5–27 A˚, respectively. The cullin fold with its kink of 80
between cullin repeats 1 and 2 is shaped to allow rotation over
BPC blades 2 and 3 toward the DDB1 C terminus without steric
clashes with DDB1 (Figure 4).
The DDB1 BPB Domain Mobility Structurally Insulates
the CUL4 Ligase from the DDB2 Module
Examination of the 11 available medium/high resolution DDB1
molecules obtained in crystallographic studies (Angers et al.,1030 Cell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc.2006; Li et al., 2006; Li et al., 2010; Scrima et al., 2008) suggest
a total BPB domain rotation range of at least 150 (Figure 4D).
Analysis of the expected energetics of rotation, as calculated
by differences in solvation energy for the individual DDB1
(BPB) versus DDB1 (BPC-BPA) interfaces (Krissinel and Henrick,
2007) predicts that the observed rotations are iso-energetic (Fig-
ure 4E). As a consequence, CRL4DDB2 is expected to rotate up to
150 establishing a ubiquitination zone restricted to 60–80 A˚.
Upon modification with the small ubiquitin like modifier NEDD8
and resultant release of RBX1, the ubiquitination zone increases
to 30-110 A˚ (Duda et al., 2008) (Figure 4D).
The overall modular architecture of CRL4DDB2 implies that
CUL4 cannot be directly activated through conformational
changes induced by DDB2 damage binding. The mobility of
the ligase arm further insulates CUL4 from DDB2. Activation of
the ligase in response to DNA damage therefore requires addi-
tional factors. We next focused on known regulators and their
role in CRL4DDB2 regulation.
The DDB2-N Terminus Is Autoubiquitinated
and Regulates DDB2 Levels after UV Irradiation
The CRL4DDB2 complex, in vivo, undergoes DDB2 autoubiquiti-
nation and degradation following UV irradiation. In contrast,
the recombinant CRL4DDB2 complex undergoes DDB2 autoubi-
quitination irrespective of the presence and absence of DNA
damage. The DDB2 subunit has previously been shown to
undergo polyubiquitination at multiple sites (Sugasawa et al.,
2005). Using mass spectrometry, in conjunction with a ubiquitin
variant lacking lysine residues required for polyubiquitination, we
identified the human DDB2 Lys residues 5, 11, 35, 40 and 151 as
themain targets for CRL4DDB2 autoubiquitination in vitro (Figures
S4A–S4D). The majority of these sites (Lys5, 11, 35 and 40) are
located within the unstructured DDB2 N terminus. When deter-
mining the human DDB1-DDB2 complex structure DDB2 aa
1–59 were absent from the electron density maps, and were
removed for subsequent structural studies. In vitro, deletion of
the DDB2 N terminus, aa 1–40 (DDB2DN), ablated the majority
of ubiquitin acceptor sites (Figure 5A). On the basis of random-
polymer-theory (Creighton, 1992) the very N terminus of DDB2
is estimated to have a root-mean-square distance of about
90 A˚ from the beginning of the DDB2 structure (aa 1-66). The
DDB2 N terminus is thereby located on the edge of the active
ubiquitination zone of the ligase.
Next, we assessed the effect of these lysine residues in cells,
in response to UV damage. A normal human fibroblast cell line,
WI38 VA13, was used to stably express HA-tagged wild-type
DDB2 or a construct in which 7 N-terminal lysines (at positions
4, 5, 11, 22, 35, 36, and 40) weremutated to arginines (DDB27KR).
DDB27KR remained associated with DDB1 andCUL4 in amanner
identical to that seen for wild-type DDB2 (Figure 5B). After block-
ing translation by cycloheximide treatment and UV irradiation,
DDB27KR showed remarkable stability compared to the wild-
type DDB2; cellular wild-type DDB2 levels mostly disappeared
1 hr after UV, whereas DDB27KR levels remained unchanged
for 5 hr (Figure 5C). Differences in total levels of wild-type
DDB2 and DDB27KR are visible as early as 30min post UV, at a
time when CSN has previously been shown to dissociate from
the complex (Groisman et al., 2003). Wild-type and DDB27KR
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Figure 4. The Structures of CRL4BDDB2 Bound to DNA Damage: Rotational Mobility of the Ligase
(A and B) Overlay of the three experimental CUL4 orientations indicating the rotational mobility of CUL4 (in gray) respective to DDB2 (depicted as surface in green)
and the bound DNA substrate (depicted in orange and black).
(C) Overlay of medium to high resolution CUL4A and CUL4B structures and schematic representation of domain boundaries.
(D) Model of CRL4DDB2 with the CUL4 arm depicted in the most distal DDB1-BPB orientations and the resultant ubiquitination hot zone indicated in light orange
and gray.
(E) Table of available medium to high resolution DDB1 structures with the corresponding orientation of CUL4 and predicted ePISA solvation energies of DDB1
(BPB) to DDB1 (BPA/BPC) interactions.
See also Figure S3.
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Figure 5. CSN-Dependent Regulation of CRL4DDB2-Mediated Ubiquitination of the DDB2 N Terminus Regulates Degradation following UV
Exposure
(A) In vitro ubiquitination assays using K-less ubiquitin and the CRL4ADDB2 complex containing either full-length DDB2 (DDB2-FL) or DDB2-DN. The reaction
mixture was subjected to immunoblot analysis with indicated antibodies.
(B) HA-tagged DDB2-FL or DDB2-7KR was stably overexpressed in a normal human fibroblast cell line. Extracts from these cells as well as the parental cell line
(indicated by -) were subjected to immunoprecipitation with anti-HA antibody and immunoblot analysis with indicated antibodies. One percent each of the input
extracts (I) and unbound fractions (U) were analyzed in parallel.
(C) The cell line stably expressing HA-DDB2-FL or HA-DDB2-7KR was exposed to UV irradiation 2 hr after treatment with 1 mM cycloheximide (CHX) in the
presence or absence of 5 mMMG132. Cells were further incubated for various times in the presence of CHX (±MG132) and whole cell extracts were subjected to
immunoblotting using indicated antibodies.
(D) In vitro ubiquitination assays were performed with wild-type CRL4ADDB2 complex and analyzed by DDB2 immunoblot. Wild-type CSN complex (lane 4)
or a complex containing a CSN5 active site mutant (lane 5) significantly inhibited the autoubiquitination of DDB2. This inhibition was relieved by the addition of
UV-irradiated DNA to the reaction (lanes 5 and 7).
(E) Small oligonucleotides containing an THF abasic sitemimic (lane 3), CPD lesion (lane 4) or 6-4PP lesion (lane 5) were sufficient to relieve the inhibition, whereas
an undamaged oligonucleotide of similar length did not affect the inhibition (lane 6). Ubiquitin-aldehyde had no effect on the reaction (lane 1 and 2).
(F) In vitro ubiquitination assays were performed with CRL4ADDB2 complex harboring the K244E DDB2 patient mutation. In contrast to wt DDB2, the inhibition by
CSNASM was not relieved upon damaged DNA addition (lane 4).
See also Figures S4 and S5 and Table S5.
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were not degraded in response to UV in the presence of MG132,
an inhibitor of the proteasome (Rapic-Otrin et al., 2002) (Fig-
ure 5C). The lysine residues at the DDB2 N terminus (aa 5-40),
which are targeted by CRL4DDB2 for autoubiquitination in vitro,
hence regulate the overall cellular concentration of DDB2 in
response to UV.
The COP9 Signalosome Mediates Activation between
DDB2 and the Ubiquitin Ligase
DDB2 is autoubiquitinated by CRL4DDB2 in cis irrespective of
the presence or absence of DNA damage in vitro. In vivo,
however, DDB2 ubiquitination and degradation proceeds in
a DNA damage specific fashion. CSN has been implicated in
CUL4 inhibition through deneddylation, and is known to dynam-
ically associate with CRL4DDB2 complexes (Groisman et al.,
2003). Dissociation of the CSN from CRL4DDB2 had previously
been observed in the presence of nucleosomes (Takedachi
et al., 2010). We first examined the effect of CSN on CRL4DDB2
autoubiquitination. DDB2, within the CRL4DDB2 complex, was
readily ubiquitinated in the presence of an E1 (UBA1) and E2
(UbcH5A), as previously observed (Sugasawa et al., 2005).
DDB2 autoubiquitination, however, was severely inhibited in
the presence of CSN (Figure 5D, lanes 4 and 6). The inhibitory
effect of CSN was observed in the presence of wild-type
CSN5, or using a CSN5 catalytic mutant deficient in deneddyla-
tion (CSNASM). We then carried out ubiquitination reactions in the
presence of irradiated DNA plasmids. Under these conditions
CSN, or CSNASM, no longer protected DDB2 from undergoing
autoubiquitination (Figure 5D, lanes 5 and 7). We then examined
the DNA specificity of activation. Short duplexes between 15 and
24bp in length containing either THF, 6-4PP or CPD (Figure 5E)
were sufficient to overcome CSN inhibition and triggered
DDB2 autoubiquitination. Duplexes containing undamaged
DNA, on the other hand, did not relieve protection (Figure 5E,
lane 6). Analogously, a DDB2 (K244E) mutant defective in
damage DNA binding (Wittschieben et al., 2005) was unable to
relieve CSN inhibition (Figure 5F). EMSA and equilibrium size-
exclusion chromatography indicated that CRL4DDB2 dissociated
from the CSN-CRL4DDB2 in the presence of small damage-con-
taining DNA duplexes (Figure S5). We thereby conclude that
substrate binding to the DDB2 subunit of CRL4DDB2 triggers
CSN release, relieves inhibition and results in an active ligase
complex. The DDB2 N terminus subsequently becomes sub-
jected to CRL4DDB2 autoubiquitination, which triggers cellular
DDB2 degradation in response to UV irradiation.
Previous studies reported a deubiquitination (DUB) enzyme,
UBP12, associated with CSN preparation immunopurified
from human cells (Zhou et al., 2003). Our recombinant CSN,
overexpressed and purified to homogeneity from insect cells
(Enchev et al., 2010) (Figure S4) did not show any discernable
deubiquitination activity, in the presence or absence of damaged
DNA (Figure S4). In addition, while UBP12 DUB activity was
previously shown to be inhibited by ubiquitin-aldehyde (Zhou
et al., 2003), we observed no such effect on DNA mediated
CRL4DDB2 activation in the presence of 3.9 mM ubiquitin-alde-
hyde (Figure 5E, lanes 1 and 2), a concentration that was suffi-
cient to inhibit a control DUB added to the reaction (Figure S5E).
The CSN inhibitory properties observed in vitro are thereforeCintrinsic to the complex and not due to CSN5mediated deneddy-
lation, or CSN associated DUB activity.
In a minimal, recombinant system we have fully reconstituted
DNA damage-dependent activation of CRL4DDB2 mediated by
CSN (see Figure S5 for mapping of CSN subunits required for
protection/release). While the CRL4DDB2 complex, as depicted
in Figures 3 and 4, is active in the presence of E1 and E2 conju-
gating enzymes, its activity is inhibited by CSN. The presence of
UV damaged DNA serves to relieve CSN inhibition providing
a mechanism for DNA dependent activation of the CRL4DDB2
ligase.
The CSA DDB1 Complex Reveals a Common
Architecture of the DDB1-DCAF Family
DDB2 is a member of the large family of DCAFs, functioning as
a DNA damage specific receptor recruiting CRL4DDB2 to pyrimi-
dine dimer sites. Additional DCAFs have been described, the
majority of which serve as substrate receptors to CRL4 ubiquitin
ligases. These receptors likely do not bind DNA, but rather
recognize proteins. In the CRL4DDB2 structures, DDB2 emerges
as modular unit insulated from the CUL4 ligase. The absence of
specific interactions between DDB2 and CUL4 would principally
allow exchange of DDB2 for other WD40 containing substrate
adaptors. We thus focused on the DDB1-CSA-CUL4-RBX1
(CRL4CSA) ligase, seemingly unrelated to DDB2 besides the
WD40 repeat in its protein sequence, which functions in the
transcription-coupled repair (TCR) branch of NER (Fousteri and
Mullenders, 2008).
Cockayne syndrome (CS) is a rare congenital disease exhibit-
ing defects in the TCR branch of NER. The stalling of RNAPII
observed in the presence of damaged nucleotides tightens the
interaction between the RNAPII and the Cockayne syndrome B
(CSB) SWI/SNF ATPase. The complex of RNAPII and CSB in
turn is a prerequisite for the arrival of the Cockayne syndrome
A protein complex (CRL4CSA) (Fousteri et al., 2006). Both CSA
and CSB are required for successful repair and transcription
restart. CRL4CSA has been implicated in the ubiquitination and
subsequent degradation of CSB in a UV-dependent fashion
(Groisman et al., 2006).
We have determined the structure of the human DDB1-CSA
complex at 3.3 A˚ resolution (Figure 6). The structure was solved
by molecular replacement as outlined in Extended Experimental
Procedures. CSA comprises a seven-bladed WD40 propeller
(aa 30–365) that attaches to DDB1 through a helix-loop-helix
motif (aa 1–29). The CSA helix-loop-helix motif (HLH-box)
and theWD40 propeller were well ordered, whereas no interpret-
able electron density was found for the C terminus of CSA
(aa 364 to 396) and the C-terminal affinity tag. Irrespective of
the limited (20%) sequence identity between DDB2 and CSA,
the DDB1-CSA and DDB1-DDB2 complexes show high overall
structural similarity (backbone rmsd of 3.4 A˚ for 355 CSA/
DDB2 residues).
The location of CSA patient mutations are indicated in Fig-
ure 6B. We note that CSA mutations resulting in milder forms
of CS type III (and UV sensitive syndrome UVSS) are point
mutations expected to cause only limited structural damage.
Mutations giving rise to the more severe forms, CS type I
and II are point mutations, deletions and premature chainell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc. 1033
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Figure 6. The Structure of DDB1-CSA Suggests a Shared Architecture of CRL4DCAF Complexes
(A) Overall structure of the DDB1-CSA complex. CSA: blue, DDB1 (BPA): red, (BPB): magenta, (BPC): yellow, DDB1-CTD: gray. Schematic overview of the CSA
organization.
(B) CSA mutations linked to different phenotypes of Cockayne syndrome (white: CSI, red: CSIII/UVSS).
(C) HMM based sequence logo and corresponding secondary structure of the helix-loop-helix box (see Figure S6A for full alignment).
(D–G) Superposition using DDB1-BPA/BPC results in a similar orientation of CSA (blue) and DDB2 (green) showing the common architecture of the complexes.
Close-up view of the helix-loop-helix motif in hsCSA (E), drDDB2 (F) and hsDDB2 (G), respectively. Residues belonging to the conserved motif are indicated. See
also Figures S6 and S7 and Table S6.
1034 Cell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc.
termination mutations expected to severely compromise the
CSA structure (see Table S6 for detailed analysis of CSA patient
mutations and discussion of structure and phenotype
correlations).
The CSA-DDB1 Interaction Is Mediated through
the HLH-BOX
DDB1 comprises threeWD40 domains (BPA, BPB and BPC) and
a C-terminal a-helical domain (CTD). We found that CSA binds to
DDB1 with an N-terminal HLH-box segment formed by aa 1–29
(Figures 6A and 6D). The HLH-box localizes to a cleft between
the DDB1 propellers BPA and BPC. The two parallel HLH-box
helices, a1 and a2, pack against each other. The HLH-box inter-
action surface with DDB1 encompasses the outer surface of a1
and the N-terminal tip of a2 (aa 16–20). The majority of CSA a1
interactions with DDB1 are hydrophobic (CSA Met1, Leu5), or
contact DDB1 through H-bonds (CSA Ser6, Arg8, Gln9). While
a1 is buried deeply in the BPC DDB1 propeller, a2 is further
detached from DDB1 pointing toward the DDB1 (BPA) propeller.
CSA a2, contacts DDB1 largely through H-bonds and long-range
salt bridges comprising CSA a2 residues Arg17 and Arg20,
respectively.
Analysis of Helix-Loop-Helix Motifs Identified
in Other WD40-Containing DCAFs
The unexpected structural similarity between DDB2 and CSA
prompted us to reinvestigate whether the majority of WD40
containing DCAFs bind DDB1 in a similar fashion. In proteomic
studies approximately 50 WD40-containing DCAFs proteins
were identified as putative substrate receptors (Angers et al.,
2006; Bennett et al., 2010; He et al., 2006; Higa et al., 2006;
Jin et al., 2006). Out of the 18 WD40-containing DCAFs,
identified in at least two proteomic studies, 13 contained an
HLH-box (Figure S6A). In addition to the conserved a1 helix
(Fukumoto et al., 2008; Li et al., 2010) (Figures 6D–6G), we
now also detect conservation for helix a2. The beginning of a2
(residues +1 to +3) is composed of small and hydrophilic side
chains, followed by large hydrophobic residues (Phe, Leu and
Tyr) at the +4 position, which pack against a1 (Figure 6C). A
large, often polar, residue is found in the +6 position interacting
with DDB1 (BPA). The length of the loop between a1 and a2
appears nonconserved and varies between 2 and 7 residues.
Based on these sequence signatures, we identify DDB1-
(WD40) DCAF family members CDT2, DCAF1, WDR21,
WDR23, WDR40, WDR22, WDR32, and PHIP among others
(Figure S6) as having a HLH-box predicted to bind DDB1 in a
manner similar to DDB2 and CSA. The resultant CRL4DCAF(WD40)
complexes are expected to strongly resemble CRL4DDB2 sharing
principle properties such as ligase mobility (see Figure S6C for
a model of CRL4CSA).
We then tested the functional interplay between CRL4CSA and
CSN in vitro. We observed that CSA is also autoubiquitinated
in vitro (Figure 7A, lane 2) and that CSA autoubiquitination is in
turn inhibited by the addition of CSN (or CSNASM) (Figure 7A,
lane 3 and 5). Providing the CRL4CSA substrate CSB relieved
CSN inhibition, and led to ubiquitination of CSB and CSA (Fig-
ure 7A, lanes 4, 6, and 7, and Figure 7B). In a fully recombinant
in vitro system, damage DNA binding to CRL4DDB2, as well asCCSB binding to CRL4CSA, displaces CSN resulting in activation
of the CRL4 ligase complex.
The overall functional and regulatory constraints following
from the CRL4DDB2 (and CRL4CSA) architectures thus likely
extend to other members of the CRL4DCAF family.
DISCUSSION
The Molecular Basis of Targeting, Recruitment,
and Activation of the CRL4DDB2 Ligase in Chromatin
On the basis of our findings, we propose the following working
model for CRL4DDB2 recruitment and activation in response to
UV damage (Figure 7C): In the absence of DNA damage, nuclear
CRL4DDB2 is complexed to CSN in a nonchromatin-bound form
(Groisman et al., 2003). Following UV damage, CRL4DDB2-CSN
is recruited to DNA by its ability to interrogate nucleosomes for
the presence of 6-4PP and CPD lesions (Figure 2). CRL4DDB2 is
structurally optimized for recognition of CPDs, which due to
their small intrinsic helix destabilization frequently escape
detection by other damage surveillance factors (Figure 1).
XPC-RAD23, alone, has no significant affinity for CPD and is
unable to detect 6-4PP lesions in chromatin (Yasuda et al.,
2005). Yet XPC is essential for efficient NER repair. The ability
of CRL4DDB2 to recognize 6-4PPs, and particularly CPDs,
embedded in nucleosomes provides a pathway to recruit XPC
to lesions in chromatin and activate the ligase thus facilitating
NER (Sugasawa, 2006). We find that DNA damage binding to
DDB2 directly displaces CSN from CRL4DDB2 resulting in ligase
activation (Figure 5). Active CRL4DDB2 targets histones, XPC
and possibly additional proteins located within 100 A˚ around
the lesion for ubiquitination. The release of CSN additionally
allows CRL4DDB2 to autoubiquitinate its DDB2 subunit on the N
terminus (Figure 4). This results in degradation of DDB2 and
may function as a timing device delimiting CRL4DDB2 activity
following UV. A CRL4DDB2 variant defective in DNA binding, as
seen in patient XP82TO, retains CSN binding and does not
undergo autoubiquitination and degradation following UV
in vivo (Rapic-Otrin et al., 2002; Wittschieben et al., 2005; Take-
dachi et al., 2010) (Figure 5F).
The Architecture of the CRL4DCAF Family
The CRL4DDB2 ligase is perceived to be a special case, as it
recognizes a nonprotein substrate. The ligand, in this case
DNA, is atypically not the target for ubiquitination, but rather
proteins in its proximity are the entities ubiquitinated. In order
to examine how other CRL4DCAF complexes, structurally and
functionally, relate to CRL4DDB2, we determined the structure
of the DDB1-CSA complex. The DDB1-CSA complex, which
was shown to bind a protein epitope rather than damaged
DNA (Groisman et al., 2006) revealed a surprising overall archi-
tectural similarity to the DDB1-DDB2 complex. We find that
CSNmediated inhibition of CRL4CSA is released through addition
of CSB, similar to what has been observed for CRL4DDB2. In vivo,
the disappearance of CSN from the CRL4CSA complex (ca. 4 hr
post-UV) coincides with ubiquitination and disappearance of
CSB (Groisman et al., 2006). Structure-based sequence analysis
identified a common HLH motif within the WD40-DCAF family
expected to link other WD40 containing DCAFs to DDB1 in aell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc. 1035
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Figure 7. Model for CRL4DDB2 Ligase Activation and Release of CSN upon Damage Binding
(A) In vitro ubiquitination assays were performed with CRL4ACSA complex and analyzed by CSA immunoblot. Wild-type COP9 signalosome (CSN) complex (lane
3) or a complex containing a CSN5 active site mutant (lane 5) significantly inhibited CSA autoubiquitination. This inhibition was relieved by the addition of CSB to
the reaction (lanes 4, 6, and 7). Unspecific crossreactivity of the anti-CSA antibody is indicated with a red asterisk. CSB immunoblotting demonstrated that the
CSB substrate is also ubiquitinated in this reaction (B). (C) In complex with CSN, CRL4DDB2 is held in a ubiquitin ligase inactive state. UV irradiation induces lesion
formation in chromatin and recruitment of the CRL4DDB2-CSN complex to the site of damage. It is currently not clear if DDB2 binds on the nucleosome, or to
a looped off intermediate (Duan and Smerdon, 2010). Binding to chromatin/nucleosome results in steric displacement of CSN (involving CSN subunits 1,2,3,4,
and 6) and ligase activation. This in turn allows for ubiquitination of diverse substrates within the zone of ubiquitination including histones, XPC and DDB2.manner similar to that of CSA and DDB2. At present, we can not
exclude that alternative DCAF binding modes exist, or that
access of the DCAF HLH-box to DDB1 is subject to regulation.
Our results demonstrate that CRL4DDB2, CRL4CSA and with it
the majority of CRL4DCAF/WD40 complexes are predicted, to
share a common architectural scaffold. These CRL4 ligases
are expected to exhibit mobility, and hence, absence of direct
crosstalk between the DCAF substrate receptor and the ubiqui-
tin ligase, requiring CSN to mediate activation.1036 Cell 147, 1024–1039, November 23, 2011 ª2011 Elsevier Inc.Substrate-Dependent Crosstalk between CRL4
Complexes and the COP9 Signalosome
CSN is a key regulator of cullin-RING ligase activity. The involve-
ment of CSN in ligase regulation poses the following question:
how is a specific ligase regulated by CSN, without affecting the
remainder of cullin-RING ligases. We find that the association
and inhibition of CRL4DDB2 by CSN is relieved upon DNA
damage binding to the WD40 propeller of DDB2 (Figure 5).
A similar behavior is seen for CRL4CSA where CSB binding
displaces CSN (Figures 7A and 7B). Indeed, we observe in
CRL4DDB2-CSN negative stained EM single particle recon-
structions that the DDB2 subunit is held in close proximity
to CSN (data not shown). Other structurally related CRL4DCAF
complexes are thus expected to bind CSN in a similar fashion.
This strongly suggests that CSN release and subsequent
activation of CRL4DCAF complexes are simply triggered by
substrate binding to the DCAF within the CRL4DCAF-CSN
complex.
Protection of substrate receptors by CSN has previously been
described for the CRL1 and CRL3 families in vivo (Bornstein
et al., 2006; Schmidt et al., 2009; Zhou et al., 2003) and likely
extends to the CRL4 family (Bennett et al., 2010). The protective
effect of CSN on DDB2 autoubiquitination observed in this study
is independent of deubiquitinating enzymes, and does not
require CSN5 mediated deneddylation (see Figure S5 for CSN
subunits required for inhibition). Similar properties have been
observed for the CSN-CRL4CSA interplay, although the cellular
role of CSA autoubiquitination is unclear at present. In vivo, (1)
the intrinsic CSN deneddylase activity, (2) CSN-associated
deubiquitinases, and (3) the nonenzymatic CSN inhibition
observed are all expected to act in concert inhibiting CRL4 in
the absence of an activating cue. Further work is needed to
define the relative contribution of these three strategies (1–3) to
CSN mediated inhibition in vivo. However, all three levels of
inhibition are simultaneously relieved once DDB2 (CSA) contacts
DNA damage (CSB), as the direct contact between receptor and
substrate results in CSN dissociation and loss of receptor
protection. In light of the conserved architecture of the majority
of CRL4DCAF(WD40) complexes this provides a general mecha-
nism for regulating the CRL4 CSN interplay.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
All proteins used for structure determination were cloned into pFastBac
Dual vectors (Invitrogen) and expressed and purified from High Five cells
(Invitrogen) as outlined in Scrima et al., 2008 (see also Extended Experimental
Procedures). Purified recombinant CSB protein was provided as a kind
gift from Regina Groisman. Enzymes for neddylation such as NAE1/UBA3
and UbcH12, as well as NEDD8, were purified as N-terminal His6 fusion
proteins from Escherichia coli (Duda et al., 2008). hsUBA1, hsUbcH5A,
hsUbcH5B, hsUbiquitin and hsUbiquitin-K0 were purchased from Boston
Biochem.
Oligonucleotides Used in This Study
Single stranded DNA oligonucleotides and oligonucleotides containing tetra-
hydrofuran (THF) lesion were purchased from Sigma Aldrich. Oligonucleotides
containing the cis-syn CPDwere synthesized using phosphor-amidite building
blocks (Glenn Research, USA). Sequences of oligonucleotides used are
provided in the Tables S4 and S5.
Crystallization and Structure Solution
Crystallization conditions as well as data collection and refinement statistics
are given in Table S1.
Cellular Assays
HA-tagged DDB2 (wild-type or mutant) was stably overexpressed in a normal
human fibroblast cell line, WI38 VA13, by using the pIREShyg vector. The
transformed cells were exposed to UVC (10 J/m2) and incubated for various
times. Whole-cell extracts were prepared and analyzed by immunoblotting.CIn Vitro Ubiquitination Assays
Assays for autoubiquitination were carried out as described in Sugasawa,
2006. Antibodies used include a-hsDDB2 (AF3297, R&D Biosystems), a-XPC
(Sugasawa et al., 2005), a-CSA (GTX100145, GeneTex), a-CSB (SC10458,
Santa Cruz) and horseradish peroxidase (HRP)-conjugated secondary anti-
bodies against Goat IgG (R&D Biosystems) and rabbit IgG (GeneTex).
ACCESSION NUMBERS
The following structural coordinates have been reported: CPD#1(pdb:4A08),
CPD#2(pdb:4A09), CPD#3(pdb:4A0A), CPD#4(pdb: 4A0B), CAND1-CUL4B
(pdb:4A0C), CRL4ADDB2-DNA(pdb:4A0K), CRL4BDDB2-DNA(pdb:4A0L), and
DDB1-CSA(pdb:4A11).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six tables, and seven figures and can be found with this article online at
doi:10.1016/j.cell.2011.10.035.
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